Statin Therapy and the Risk of COVID-19: A Cohort Study of the National Health Insurance Service in South Korea
Open Access
- 10 February 2021
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 11 (2) , 116
Abstract
We aimed to investigate whether statin therapy is associated with the incidence of coronavirus disease 2019 (COVID-19) among the South Korean population. In addition, we examined whether statin therapy affects hospital mortality among COVID-19 patients. The National Health Insurance Service (NHIS)-COVID-19 database in South Korea was used for data extraction for this population-based cohort study. A total of 122,040 adult individuals, with 22,633 (18.5%) in the statin therapy group and 101,697 (91.5%) in the control group, were included in the analysis. Among them, 7780 (6.4%) individuals were diagnosed with COVID-19 and hospital mortality occurred in 251 (3.2%) COVID-19 cases. After propensity score matching, logistic regression analysis showed that the odds of developing COVID-19 were 35% lower in the statin therapy group than in the control group (odds ratio: 0.65, 95% confidence interval: 0.60 to 0.71; p < 0.001). Regarding hospital mortality among COVID-19 patients, the multivariable model indicated that there were no differences between the statin therapy and control groups (odds ratio: 0.74, 95% confidence interval: 0.52 to 1.05; p = 0.094). Statin therapy may have potential benefits for the prevention of COVID-19 in South Korea. However, we found that statin therapy does not affect the hospital mortality of patients who are diagnosed with COVID-19.Keywords
This publication has 23 references indexed in Scilit:
- Inhibition of MLC Phosphorylation Restricts Replication of Influenza Virus—A Mechanism of Action for Anti-Influenza AgentsPLOS ONE, 2011
- Confronting the next influenza pandemic with anti‐inflammatory and immunomodulatory agents: why they are needed and how they might workInfluenza and Other Respiratory Viruses, 2009
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) StatementEpidemiology, 2007
- Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemiaNature Medicine, 2006
- Atorvastatin inhibits inflammatory hypernociceptionBritish Journal of Pharmacology, 2006
- Pandemic Influenza: A Potential Role for Statins in Treatment and ProphylaxisClinical Infectious Diseases, 2006
- Low high-density lipoprotein cholesterol and cardiovascular disease: Risk reduction with statin therapyAmerican Heart Journal, 2006
- PLEIOTROPIC EFFECTS OF STATINSAnnual Review of Pharmacology and Toxicology, 2005
- Role for Influenza Virus Envelope Cholesterol in Virus Entry and InfectionJournal of Virology, 2003
- Reducing Bias in Observational Studies Using Subclassification on the Propensity ScoreJournal of the American Statistical Association, 1984